Prosecution Insights
Prosecution Insights
36 pending office actions • 23 art units • 34 examiners • 1 of 36 (3%) have an AI response strategy ready • 39 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 4 (11%) |
| §103 only | 7 (19%) |
| §102 only | 2 (6%) |
| §112 only | 4 (11%) |
| Double-patenting only | 3 (8%) |
| Double-patenting + other | 5 (14%) |
| Multi-statute (no §101) | 10 (28%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FETTEROLF, BRANDON J | 2 | 51.4% | +17.1% |
| HAGHIGHATIAN, MINA | 2 | 45.8% | +39.7% |
| GAMBLE JR, RANDALL LEE | 1 | 50.0% | +25.8% |
| REICHERT, RACHELLE LEIGH | 1 | 30.0% | +33.7% |
| HEIN, DEVIN C | 1 | 46.0% | +29.8% |
| ROZOF, TIMOTHY R | 1 | 72.7% | +23.9% |
| CHENG, KAREN | 1 | 76.3% | +27.1% |
| PETRASH, HILARY ANN | 1 | 63.9% | +53.5% |
| MOTEVALLI, OROD | 1 | 0.0% | +0.0% |
| COLLINS, CYNTHIA E | 1 | 82.4% | +8.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262934 | CLINICAL ENDPOINT ADJUDICATION SYSTEM AND METHOD | PATEL, SHERYL GOPAL | 17d overdue |
| 18590826 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | HAGHIGHATIAN, MINA | 17d overdue |
| 17998275 | ATR INHIBITORS FOR THE TREATMENT OF CANCER | HIRAKIS, SOPHIA P | 10d overdue |
| 18855182 | PREDICTING ALBUMINURIA USING MACHINE LEARNING | HEIN, DEVIN C | 12d |
| 18452008 | PHARMACEUTICAL PROCESS AND INTERMEDIATES | OH, TAYLOR V | 15d |
| 18564778 | METHODS OF TREATING BREAST CANCER | FETTEROLF, BRANDON J | 16d |
| 18550546 | SYSTEM AND METHOD FOR ONLINE DETECTION OF A POST-TRANSLATIONAL MODIFICATION OF A POLYPEPTIDE | BERKE-SCHLESSEL, DAVID W | 16d |
| 18552014 | FORMULATION COMPRISING CERALASERTIB | LEE, SIN J | 21d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17772187 | DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE | HAGHIGHATIAN, MINA | 19d overdue |
| 18590826 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | HAGHIGHATIAN, MINA | 17d overdue |
| 18855182 | PREDICTING ALBUMINURIA USING MACHINE LEARNING | HEIN, DEVIN C | 12d |
| 18564778 | METHODS OF TREATING BREAST CANCER | FETTEROLF, BRANDON J | 16d |
| 18753316 | ANTIBODY MOLECULES AND CONJUGATES | PETRASH, HILARY ANN | 54d |
| 18855064 | PREDICTING DISEASE PROGRESSION IN PORTAL HYPERTENSION USING MACHINE LEARNING | REICHERT, RACHELLE LEIGH | 70d |
| 19099577 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | GAMBLE JR, RANDALL LEE | — |
| 18853504 | COMBINATION THERAPY FOR TREATING CANCER | FETTEROLF, BRANDON J | — |
| Art Unit | Apps |
|---|---|
| 1623 | 3 |
| 3686 | 2 |
| 1626 | 2 |
| 1613 | 2 |
| 1638 | 2 |
| 1625 | 2 |
| 1674 | 2 |
| 1616 | 2 |
| 1795 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19099577 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | GAMBLE JR, RANDALL LEE | 1795 | §102§103§112 | Non-Final OA | — | Pending | Jan 29, 2025 |
| 18855064 | PREDICTING DISEASE PROGRESSION IN PORTAL HYPERTENSION USING MACHINE LEARNING | REICHERT, RACHELLE LEIGH | 3686 | §101§112 | Non-Final OA | 70d | Pending | Oct 08, 2024 |
| 18855182 | PREDICTING ALBUMINURIA USING MACHINE LEARNING | HEIN, DEVIN C | 3686 | §101§103 | Final Rejection | 12d | Pending | Oct 08, 2024 |
| 18853504 | COMBINATION THERAPY FOR TREATING CANCER | FETTEROLF, BRANDON J | — | DP | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18837956 | METHODS OF TREATING PROSTATE CANCER | ROZOF, TIMOTHY R | — | §103 | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18775391 | CHEMICAL COMPOUNDS | CHENG, KAREN | 1623 | DP | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18753316 | ANTIBODY MOLECULES AND CONJUGATES | PETRASH, HILARY ANN | 1644 | §112Other | Non-Final OA | 54d | Pending | Jun 25, 2024 |
| 18718844 | CERTAIN 3-AZABICYCLO[3.1.0]HEXANES AS GLP-1 RECEPTOR MODULATORS | MOTEVALLI, OROD | 1628 | §112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18439897 | COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF CAS9-BASED KNOCK-IN STRATEGIES | COLLINS, CYNTHIA E | 1662 | §102§103 | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18435476 | TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOUS | HADDAD, MAHER M | — | §102§103§112DP | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18291671 | TREATMENT OF LUPUS | NATARAJAN, MEERA | — | §102 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18417379 | VACCINE | GRIZER, CASSANDRA SENN | 1672 | §103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18413349 | OSIMERTINIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER | WEBB, WALTER E | 1612 | §103 | Final Rejection | — | Pending | Jan 16, 2024 |
| 18539471 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | HEASLEY, MEGHAN CHRISTINE | 1626 | §112 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18564778 | METHODS OF TREATING BREAST CANCER | FETTEROLF, BRANDON J | 1626 | §102§103§112 | Non-Final OA | 16d | Pending | Nov 28, 2023 |
| 18554014 | COMPOSITIONS AND METHODS FOR SITE-SPECIFIC MODIFICATION | YU, DAVID TUYANG | 1635 | §102 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18552014 | FORMULATION COMPRISING CERALASERTIB | LEE, SIN J | 1613 | §103§112 | Final Rejection | 21d | Pending | Sep 22, 2023 |
| 18550546 | SYSTEM AND METHOD FOR ONLINE DETECTION OF A POST-TRANSLATIONAL MODIFICATION OF A POLYPEPTIDE | BERKE-SCHLESSEL, DAVID W | 1651 | §101§102§103§112 | Non-Final OA | 16d | Pending | Sep 14, 2023 |
| 18550548 | CONTROL OF MULTI-GENE EXPRESSION USING SYNTHETIC PROMOTERS | VIVLEMORE, TRACY ANN | 1638 | §102§103§112 | Final Rejection | — | Pending | Sep 14, 2023 |
| 18549852 | METHODS FOR TREATING SMALL CELL LUNG CANCER AND OTHER NEUROENDOCRINE CANCERS | CHANDRAKUMAR, NIZAL S | 1625 | §103DPOther | Non-Final OA | 62d | Pending | Sep 08, 2023 |
| 18452008 | PHARMACEUTICAL PROCESS AND INTERMEDIATES | OH, TAYLOR V | 1625 | §102§103§112 | Non-Final OA | 15d | Pending | Aug 18, 2023 |
| 18448559 | COMBINATION THERAPIES FOR TREATMENT OF CIRRHOSIS WITH PORTAL HYPERTENSION | REDWOOD, CHRISTOPHER EVAN | 1629 | §103 | Non-Final OA | 9d overdue | AI Ready | Aug 11, 2023 |
| 18262934 | CLINICAL ENDPOINT ADJUDICATION SYSTEM AND METHOD | PATEL, SHERYL GOPAL | 3685 | §101 | Non-Final OA | 17d overdue | Pending | Jul 26, 2023 |
| 18248280 | TREATMENT OF FLARES IN LUPUS | XIE, XIAOZHEN | 1674 | DP | Final Rejection | — | Pending | Apr 07, 2023 |
| 18248108 | COMBINATION THERAPY FOR TREATING CANCER | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §112 | Final Rejection | — | Pending | Apr 06, 2023 |
| 18177374 | BINDING MOLECULES AGAINST FRa | KAUFMAN, CLAIRE M | 1674 | §112DPOther | Non-Final OA | 60d | Pending | Mar 02, 2023 |
| 17998275 | ATR INHIBITORS FOR THE TREATMENT OF CANCER | HIRAKIS, SOPHIA P | 1623 | §102§103§112Other | Non-Final OA | 10d overdue | Pending | Nov 09, 2022 |
| 17893445 | METHODS FOR GENERATING PRIMARY IMMUNE CELLS | VAN BUREN, LAUREN K | 1638 | §101§102DP | Non-Final OA | — | Pending | Aug 23, 2022 |
| 17772187 | DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE | HAGHIGHATIAN, MINA | 1616 | §103 | Non-Final OA | 19d overdue | Pending | Apr 27, 2022 |
| 17754844 | MODULATORS OF PNPLA3 EXPRESSION | CHONG, KIMBERLY | 1636 | §102§103§112 | Non-Final OA | 69d | Pending | Apr 13, 2022 |
| 17765585 | METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES | CHATTIN, AMY MARIE | 1643 | §103 | Non-Final OA | 15d overdue | Pending | Mar 31, 2022 |
| 18590826 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | HAGHIGHATIAN, MINA | 1616 | §103§112 | Non-Final OA | 17d overdue | Pending | Feb 28, 2024 |
| 18577168 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | BECKHARDT, LYNDSEY MARIE | 1613 | §103§112DP | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18577176 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | LIPPERT, JOHN WILLIAM | 1615 | §102§103DP | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18012705 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ATR INHIBITOR | KIM, SEONG JONG | 1623 | §103 | Non-Final OA | — | Pending | Dec 23, 2022 |
| 18052840 | COMPOSITION FOR TREATMENT AND PREVENTION OF COVID-19 | GODDARD, LAURA B | 1642 | §103 | Final Rejection | — | Pending | Nov 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial